Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/1999
12/02/1999WO1999061030A1 UTILIZATION OF 2-HYDROXY-4-TRIFLUOROMETHYLBENZOÏC ACID DERIVATIVES AS INHIBITORS OF THE ACTIVATION OF THE NUCLEAR TRANSCRIPTION FACTORS NF-λB
12/02/1999WO1999061029A1 Sleep inducing agent
12/02/1999WO1999061027A1 Combination therapy for treatment of refractory depression
12/02/1999WO1999061025A1 Microemulsion preconcentrates containing a piperidine substance p antagonist
12/02/1999WO1999061024A1 Peripheral benzodiazepine receptor ligands
12/02/1999WO1999061023A1 Cocaine receptor binding ligands
12/02/1999WO1999061008A2 Compositions and methods for alleviating impaired mental function, memory loss and reducing recovery time in anaesthetized mammals
12/02/1999WO1999060997A1 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug
12/02/1999WO1999060987A2 Control of pain with endogenous cannabinoids
12/02/1999WO1999052519A3 Methods for treating neuropsychiatric disorders
12/02/1999WO1999052518A3 New treatments for nervous disorders
12/02/1999WO1999051565A9 Novel local anesthetic compounds and uses
12/02/1999WO1999046381A9 Human fgf gene and gene expression products
12/02/1999WO1999043286A3 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/02/1999WO1999036064A3 Methods of treating tardive dyskinesia and other movement disorders
12/02/1999DE19821788C1 Transdermales Therapeutisches System (TTS) Pergolid enthaltend Transdermal therapeutic system (TTS) containing pergolide
12/02/1999CA2334940A1 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in sca1
12/02/1999CA2333537A1 N-substituted derivatives of 5-oxyiminobarbituric acid
12/02/1999CA2333157A1 Novel substituted imidazole compounds
12/02/1999CA2333006A1 Calmodulin related protein
12/02/1999CA2332863A1 Use of 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor nf-.kappa.b
12/02/1999CA2332825A1 Peripheral benzodiazepine receptor ligands
12/02/1999CA2332786A1 Identification of broadly reactive dr restricted epitopes
12/02/1999CA2332459A1 Heterocyclic compounds and methods to treat cardiac failure and other disorders
12/02/1999CA2332402A1 Novel 2-alkyl substituted imidazole compounds
12/02/1999CA2329506A1 Alg-2lp, alg-2 like molecules and uses therefor
12/02/1999CA2329274A1 Interleukin-21
12/02/1999CA2329072A1 Human transmembrane proteins
12/02/1999CA2329053A1 Human socs proteins
12/02/1999CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/01/1999EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999EP0960111A1 Morphine derivatives with analgesic activity
12/01/1999EP0960110A1 3-ARYL SUBSTITUTED PYRAZOLO 4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF 1?) SPECIFIC LIGANDS
12/01/1999EP0960106A1 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
12/01/1999EP0960105A1 Benzofurazan compounds which enhance ampa receptor activity
12/01/1999EP0960101A1 4-aminoethoxyindazole derivatives
12/01/1999EP0959903A1 NOVEL FabD
12/01/1999EP0959890A1 Medicines for treating dementia or cognitive disorder, which comprises asiatic acid derivatives
12/01/1999EP0959888A1 Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
12/01/1999EP0959887A1 Pharmaceutically active compounds and methods of use
12/01/1999EP0959883A1 Inhibitors of farnesyl-protein transferase
12/01/1999EP0959882A1 N-linked ureas and carbamates of heterocyclic thioesters
12/01/1999EP0959875A1 Active substance carrier for releasing apomorphine into the buccal cavity
12/01/1999EP0788491B1 6-polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
12/01/1999EP0630244B1 Muscarinic agonists
12/01/1999CN1237179A 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivatives
12/01/1999CN1237168A Bicyclic aryl carboxamides and their therapeutic use
12/01/1999CN1237162A Indene inhibitors of COX-2
12/01/1999CN1236780A Pyrazolopyrimidines and pyrazolotriazines
12/01/1999CN1046942C Imidazopyridines
11/1999
11/30/1999USRE36420 Percutaneous preparation of tulobuterol
11/30/1999US5994513 Oncoprotein protein kinase
11/30/1999US5994396 Nervous system disorders; autoimmune diseases; antiinflammatory agents
11/30/1999US5994387 Pyrrolidinyl methyl indole salt
11/30/1999US5994381 Antipyretics; antiinflammatory agents; analgesics
11/30/1999US5994379 Analgesics; antiinflammatory agent; antipyretics
11/30/1999US5994373 Cognition activators; gastrointestinal disorders; psychological disorders
11/30/1999US5994372 Peripherally active anti-hyperalgesic opiates
11/30/1999US5994369 Substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
11/30/1999US5994366 Psychological disorders
11/30/1999US5994363 Amelioration of apomorphine adverse effects
11/30/1999US5994353 Aromatic compounds and pharmaceutical compositions containing them
11/30/1999US5994350 Cardiovascular disorders; central nervous system disorders; gastrointestinal disorders; respiratory system disorders
11/30/1999US5994347 For a process for treatment of anxiety and tension
11/30/1999US5994333 Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
11/30/1999US5994332 Antiinflammatory agents; immunomodulators; skin disorders
11/30/1999US5994325 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
11/30/1999US5994322 Compositions for preventing dementia
11/30/1999US5994320 Antisense oligonucleotides and methods for treating central nervous system tumors
11/30/1999US5994312 Peptidyl compounds
11/30/1999US5994293 Peptidyl compounds and their therapeutic use
11/30/1999US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999US5994096 Regulator
11/30/1999US5993779 Interrupting an aorta at least at two sites, forming an isolated segment including branched parts of radicular arteries, feeding the spinal cord between the sites of interruption, bringing to ischemia, administering glu or asp
11/25/1999WO1999060145A1 Mutant herpes simplex viruses and uses thereof
11/25/1999WO1999060024A1 Methods for amyloid removal using anti-amyloid antibodies
11/25/1999WO1999060021A2 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
11/25/1999WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999WO1999059997A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
11/25/1999WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999WO1999059974A1 Tetraisoquinololine derivatives as modulators of dopamine d3 receptors
11/25/1999WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999WO1999059617A2 Immunoregulator
11/25/1999WO1999059606A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
11/25/1999WO1999059597A1 Ionophore containing composition for modulating amyloidosis
11/25/1999WO1999059596A1 Glucocorticoid receptor antagonists for the treatment of dementia
11/25/1999WO1999059593A1 Combination therapy for treatment of depression
11/25/1999WO1999059573A1 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
11/25/1999WO1999059571A1 Use of amyloid inhibitors for modulating neuronal cell death
11/25/1999WO1999059563A2 Cabergoline and pramipexole for treating cns diseases, especially parkinson's disease
11/25/1999WO1999059558A1 Transdermal therapeutic system containing pergolide
11/25/1999WO1999059553A1 Effervescent preparations
11/25/1999WO1999059524A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
11/25/1999WO1999059499A2 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
11/25/1999WO1999050249A3 Pyrimidines and triazines as integrin antagonists
11/25/1999WO1999048507A3 Steroidal saponins for treating alzheimer's disease
11/25/1999WO1999048484A3 Use of cabergoline in the treatment of restless legs syndrome
11/25/1999WO1999047545A3 Inhibitors of caspases
1 ... 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 ... 1833